相关实验视频

Updated: Jun 27, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.4K

乳腺癌中的多基因表达试验:文献综述

Tsung-Yen Hsieh1, Chi-Cheng Huang1,2, Ling-Ming Tseng1,3

  • 1Division of Breast Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei.

Translational cancer research
|October 29, 2025
PubMed
概括

多基因表达测试,如Oncotype DX,MammaPrint和Prosigna,可以改善乳腺癌的预后和治疗选择. 尽管存在成本和可访问性等挑战,但这些分子工具对于精确瘤学和缓和治疗至关重要.

关键词:
乳腺癌是什么? 乳腺癌是什么母亲的印记 印记型 DX 是一种型.普罗西尼加 (Prosigna) 是一个基因表达测试试验 基因表达测试试验

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.2K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...